14 results
8-K
EX-10.7
QTTB
Q32 Bio Inc.
26 Mar 24
Q32 Bio Announces Closing of Merger with Homology Medicines and Concurrent Private Placement of $42 Million
9:57pm
” shall not include any person who, under the applicable standards of professional conduct then prevailing, would have a conflict of interest … by the Company, (B) Indemnitee shall have reasonably concluded that there may be a conflict of interest between the Company and Indemnitee in the conduct
8-K
EX-10.6
QTTB
Q32 Bio Inc.
26 Mar 24
Q32 Bio Announces Closing of Merger with Homology Medicines and Concurrent Private Placement of $42 Million
9:57pm
have a conflict of interest in representing either the Company or Indemnitee in an action to determine Indemnitee’s rights under this Agreement … have reasonably concluded that there may be a conflict of interest between the Company and Indemnitee in the conduct of such defense, (C) the Company
8-K
EX-10.2
QTTB
Q32 Bio Inc.
26 Mar 24
Q32 Bio Announces Closing of Merger with Homology Medicines and Concurrent Private Placement of $42 Million
9:57pm
believe that a conflict of interest is likely to exist if the same counsel were to represent such Indemnified Party and the Indemnifying Party (in which
S-4
EX-10.37
QTTB
Q32 Bio Inc.
15 Dec 23
Registration of securities issued in business combination transactions
7:15pm
available to it that are different from or additional to those available to the other party or that a conflict of interest between such parties may
S-4
EX-10.36
QTTB
Q32 Bio Inc.
15 Dec 23
Registration of securities issued in business combination transactions
7:15pm
exists of a conflict of interest between the Indemnifying Party and the Indemnified Party with respect to the Third Party Claim that cannot be waived
8-K
EX-3.1
p6hdp652j28u79g rlep
18 Dec 20
Amendments to Articles of Incorporation or Bylaws
4:01pm
DEF 14A
b493e33xqim4dl ek8s
25 Apr 19
Definitive proxy
4:54pm
- Prev
- 1
- Next